Mela-Act 2.0 Depigmentation & Radiance Cream

Helps reduce the appearance of dark spots
Supports a more even-looking skin tone
Helps improve the appearance of hyperpigmentation
Promotes brighter and more radiant-looking skin
Helps address dull and uneven complexion
Contains Tranexamic Acid, Kojic Acid & Arbutin
Enriched with Mulberry Extract & Vitamin E
Suitable for nighttime skincare
Helps leave skin looking smoother and more luminous

Mela-Act 2.0 Depigmentation & Radiance Cream

Mela-Act 2.0 Depigmentation & Radiance Cream is a targeted night-use skincare cream formulated to improve the appearance of hyperpigmentation, dark spots, uneven skin tone, and dullness. Its brightening blend includes Tranexamic Acid, Kojic Acid, Arbutin, Mulberry Extract, Vitamin E, and Magnesium, which work together to support a more even-toned and radiant-looking complexion.

The lightweight formula is designed for evening use and absorbs comfortably into the skin while helping provide hydration and skin conditioning. Regular use can help promote a smoother, brighter, and more luminous appearance.

Key Benefits

Helps improve the appearance of hyperpigmentation
Supports a more even-looking skin tone
Helps reduce the appearance of dark spots
Enhances skin radiance and brightness
Helps improve the appearance of dull skin
Provides moisturizing and conditioning benefits
Lightweight texture with comfortable absorption
Suitable for regular nighttime skincare

Key Ingredients

Tranexamic Acid 10% – targeted brightening support
Kojic Acid 2% – helps improve the appearance of pigmentation
Arbutin 1.5% – supports a more even-looking complexion
Mulberry Extract 1% – brightening botanical extract
Vitamin E 1% – antioxidant and conditioning support
Magnesium 1% – included in the brightening formulation

How to Use

Apply a small, pearl-sized amount to clean, dry skin in the evening. Spread a thin layer evenly over the face and neck and gently massage until absorbed. During the daytime, use a broad-spectrum sunscreen as part of your skincare routine.